Cadoo KA, Grisham RN, O'Cearbhaill RE, Boucicaut NN, et al. A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer. Gynecol Oncol 2020 Jan 17. pii: S0090-8258(20)30060.
PMID: 31959492